FDA Adverse Event Malfunction Summary report: N

OBALON BALLOON SYSTEM

MDR report key: 8010392 · Received October 26, 2018

Report

Report Number
3009256831-2018-00655
Event Type
Malfunction
Date Received
October 26, 2018
Date of Event
September 28, 2018
Report Date
October 26, 2018
Manufacturer
OBALON THERAPEUTICS, INC.
Product Code
LTI
UDI-DI
00859810006067
PMA / PMN Number
P160001
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEFLATED BALLOON WAS THE FIRST BALLOON IMPLANTED OF THE THREE-BALLOON SYSTEM AND WAS IMPLANTED FOR A DURATION OF 184 DAYS. THE BALLOON INFLATION PRESSURE WAS RECORDED AS WITHIN THE PRESSURE RANGE AT IMPLANTATION. OBALON INITIATED A TECHNICAL INVESTIGATION OF THE PRODUCT FAILURE INCLUDING FULL ENGINEERING ANALYSIS ON THE RETURNED BALLOONS. ALL BALLOON VOLUMES WERE WITHIN THE EXPECTED VOLUME SPECIFICATION. OBALON VISUALLY INSPECTED THE BALLOONS WITH LIGHT MICROSCOPY AND MATERIAL FATIGUE WAS ONLY OBSERVED ON THE DEFLATED BALLOON. SCANNING ELECTRON MICROSCOPE (SEM) IMAGES WERE OBTAINED FOR THE DEFLATED BALLOON AND A BREACH WAS IDENTIFIED IN THE AREA OF THE MATERIAL FATIGUE. THE BREACH IN THE BALLOON IS THE LIKELY CAUSE FOR DEFLATION. A POTENTIAL ROOT CAUSE OF THE DEFLATION COULD BE MATERIAL FATIGUE RESULTING FROM A LOW BALLOON PRESSURE; HOWEVER, THE ACTUAL ROOT CAUSE REMAINS UNKNOWN. DEFLATION IS A KNOWN RISK; THE FREQUENCY OF BALLOON DEFLATIONS HAS NOT EXCEEDED THE FREQUENCY IDENTIFIED IN THE LABELING. OBALON'S LABELING ADDRESSES THE REPORTED EVENT WITH WARNINGS FOR MONITORING PATIENTS FOR DEFLATION SYMPTOMS. OBALON'S LABELING STATES, "PATIENTS REPORTING A LOSS OF FULLNESS, INCREASED HUNGER, AND/OR WEIGHT GAIN SHOULD BE EXAMINED BY RADIOGRAPH, AS THIS MAY BE A SIGN OF BALLOON DEFLATION. ADDITIONALLY, ANY INCREASE IN NAUSEA, VOMITING AND/OR CRAMPING AFTER INITIAL SYMPTOMS HAVE SUBSIDED MAY INDICATE A DEFLATED BALLOON. PATIENTS SHOULD BE EVALUATED BY RADIOGRAPH AND ENDOSCOPIC VISUALIZATION MIGHT BE REQUIRED IF THE STATE OF INFLATION CANNOT BE DETERMINED RADIOGRAPHICALLY. IN THE EVENT OF BALLOON DEFLATION, THE BALLOON SHOULD BE REMOVED AS SOON AS POSSIBLE." AND "IT IS EXPECTED FOR PATIENTS TO EXPERIENCE SOME DEGREE OF NAUSEA, VOMITING, AND CRAMPING WITHIN THE FIRST WEEK AFTER EACH BALLOON ADMINISTRATION. SEVERE SYMPTOMS DURING THAT TIME OR NEW SYMPTOMS OCCURRING AFTER THE FIRST WEEK COULD INDICATE A PREMATURE BALLOON DEFLATION. A SUDDEN LOSS OF FULLNESS OR A SUDDEN INCREASE IN FEELINGS OF HUNGER MAY ALSO INDICATE A POTENTIAL BALLOON DEFLATION. IN THESE CIRCUMSTANCES, RADIOGRAPHIC IMAGING SHOULD BE CONSIDERED TO RULE OUT A POTENTIAL BALLOON DEFLATION. BALLOON VALVES ARE RADIOPAQUE AND THE OUTLINE OF AN INFLATED BALLOON WILL HAVE AN ELLIPTICAL OR CIRCULAR PERIMETER. IF ALL BALLOONS CANNOT BE VISUALIZED WITH A SINGLE X-RAY VIEW, A SECOND X-RAY VIEW SHOULD ALSO BE EVALUATED."

Description of Event or Problem · 1

A FEMALE PATIENT WITH A FIRST BALLOON PLACEMENT OF (B)(6) 2018, SECOND BALLOON PLACEMENT OF (B)(6) 2018, AND THIRD BALLOON PLACEMENT OF (B)(6) 2018. REMOVAL WAS SCHEDULED FOR (B)(6) 2018. ON (B)(6), THE PATIENT EXPERIENCED A NEW ONSET OF SYMPTOMS OF NAUSEA AND VOMITING ON AND REPORTED THESE NEW SYMPTOMS TO THE PRESCRIBING PHYSICIAN. SINCE THE REMOVAL WAS SCHEDULED FOR THE FOLLOWING MORNING AND THE SYMPTOMS DID NOT APPEAR TO BE LIFE-THREATENING, BALLOON REMOVAL WAS NOT RESCHEDULED AND OCCURRED ON (B)(6) 2018. DURING RETRIEVAL, ONE BALLOON WAS IDENTIFIED AS DEFLATED IN THE DISTAL PART OF THE STOMACH, ONE BALLOON WAS PARTIALLY INFLATED IN THE STOMACH, AND ONE BALLOON WAS FULLY INFLATED IN THE STOMACH. ALL BALLOONS WERE SUCCESSFULLY REMOVED BY ENDOSCOPY WITHOUT COMPLICATION AND WERE RETURNED TO OBALON FOR INVESTIGATION. THERE WAS NO SERIOUS INJURY DUE TO THE DEFLATED BALLOON.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
849196 OBALON BALLOON SYSTEM INTRAGASTIC BALLOON LTI OBALON THERAPEUTICS, INC. 7600-0001 170909403 00859810006067

Patients

Seq Age Sex Outcome Treatment
1 52 YR